back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-05-03 09:53 Tx date 2024-05-02 |
$PHRX
Pharmadrug Inc. |
Goldman, Zalman
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2024-05-03 09:52 Tx date 2024-05-02 |
$PHRX
Pharmadrug Inc. |
Goldman, Zalman
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-11 14:00 Tx date 2024-01-11 |
$PHRX
Pharmadrug Inc. |
Li, Ka Yin Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-500,000 vol |
0 | |
| Filed 2024-01-11 13:57 Tx date 2024-01-11 |
$PHRX
Pharmadrug Inc. |
Li, Ka Yin Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
+500,000 vol |
500,000 | |
| Filed 2024-01-11 13:57 Tx date 2024-01-11 |
$PHRX
Pharmadrug Inc. |
Li, Ka Yin Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
+500,000 vol |
||
| Filed 2024-01-11 11:11 Tx date 2020-08-25 |
$PHRX
Pharmadrug Inc. |
Li, Ka Yin Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$-12,500
-250,000 vol $0.05 each |
-250,000 | |
| Filed 2020-08-31 11:06 Tx date 2020-08-25 |
$PHRX
Pharmadrug Inc. |
Li, Ka Yin Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,500
+250,000 vol $0.05 each |
||
| Filed 2023-12-18 16:25 Tx date 2023-11-07 |
$PHRX
Pharmadrug Inc. |
Appleby, Kyle Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2023-12-18 16:13 Tx date 2023-10-20 |
$PHRX
Pharmadrug Inc. |
Appleby, Kyle Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-18 09:08 Tx date 2023-11-07 |
$PHRX
Pharmadrug Inc. |
McClory, Paul Gerard Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
924,286 | |
| Filed 2023-12-18 09:05 Tx date 2023-11-07 |
$PHRX
Pharmadrug Inc. |
Vassev, Nikolai
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
642,857 | |
| Filed 2023-12-18 09:00 Tx date 2023-11-07 |
$PHRX
Pharmadrug Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,107,143 | |
| Filed 2023-12-18 08:56 Tx date 2023-11-07 |
$PHRX
Pharmadrug Inc. |
Steen, Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,000,000 vol |
3,000,000 | |
| Filed 2023-10-24 13:52 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
McClory, Paul Gerard Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,572 vol |
174,286 | |
| Filed 2023-10-24 13:39 Tx date 2022-11-01 |
$PHRX
Pharmadrug Inc. |
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Cloud Management LLP (Indirect Ownership)
|
Options
52 - Expiration of options
|
-750,000 vol |
0 | |
| Filed 2023-10-24 13:37 Tx date 2022-11-01 |
$PHRX
Pharmadrug Inc. |
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Harry Resin (Indirect Ownership)
|
Options
52 - Expiration of options
|
-2,000,000 vol |
0 | |
| Filed 2023-10-24 13:34 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Cloud Management LLP (Indirect Ownership)
|
Options
37 - Stock split or consolidation
|
-642,857 vol |
||
| Filed 2023-10-24 13:34 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Harry Resin (Indirect Ownership)
|
Options
37 - Stock split or consolidation
|
-1,714,286 vol |
||
| Filed 2023-10-24 13:34 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Could Management LLC (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-857,143 vol |
||
| Filed 2023-10-24 13:28 Tx date 2023-07-23 |
$PHRX
Pharmadrug Inc. |
Van Slyke, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,000,000 vol |
0 | |
| Filed 2023-10-24 13:25 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Van Slyke, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,714,286 vol |
||
| Filed 2023-10-24 13:18 Tx date 2022-04-13 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-500,000 vol |
0 | |
| Filed 2023-10-24 13:16 Tx date 2022-04-13 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-220,000 vol |
500,000 | |
| Filed 2023-10-24 13:16 Tx date 2022-04-13 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-200,000 vol |
||
| Filed 2023-10-24 13:15 Tx date 2022-04-13 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-500,000 vol |
720,000 | |
| Filed 2023-10-24 13:13 Tx date 2022-04-13 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-200,000 vol |
||
| Filed 2023-10-24 13:11 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,572 vol |
||
| Filed 2023-10-24 13:11 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
||
| Filed 2023-10-24 13:09 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-188,571 vol |
||
| Filed 2023-10-24 12:05 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,572 vol |
||
| Filed 2023-10-24 12:05 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,572 vol |
174,286 | |
| Filed 2023-10-24 12:04 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Vassev, Nikolai
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,572 vol |
142,857 | |
| Filed 2023-10-24 11:56 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Vassev, Nikolai
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
||
| Filed 2023-10-24 11:56 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Vassev, Nikolai
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
142,858 | |
| Filed 2023-10-24 11:55 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Vassev, Nikolai
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
571,429 | |
| Filed 2023-10-24 11:53 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Van Slyke, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,714,286 vol |
285,714 | |
| Filed 2023-10-24 11:53 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Van Slyke, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,714,286 vol |
||
| Filed 2023-10-24 11:50 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
||
| Filed 2023-10-24 11:50 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
174,287 | |
| Filed 2023-10-24 11:50 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
||
| Filed 2023-10-24 11:47 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
||
| Filed 2023-10-24 11:47 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
602,858 | |
| Filed 2023-10-24 11:46 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-188,571 vol |
1,031,429 | |
| Filed 2023-10-24 11:46 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-188,571 vol |
||
| Filed 2023-10-24 11:42 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Quong, Al
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
178,572 | |
| Filed 2023-10-24 11:41 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Quong, Al
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-642,857 vol |
607,143 | |
| Filed 2023-10-24 11:38 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
High Fusion Inc. (formerly Nutritional High International Inc.)
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-171,429 vol |
28,571 | |
| Filed 2023-10-24 11:36 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
High Fusion Inc. (formerly Nutritional High International Inc.)
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-7,674,099 vol |
1,279,016 | |
| Filed 2023-10-24 11:32 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
McClory, Paul Gerard Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
174,287 | |
| Filed 2023-10-24 11:32 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
McClory, Paul Gerard Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
||
| Filed 2023-10-24 11:31 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
McClory, Paul Gerard Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-428,571 vol |
602,858 | |
| Filed 2023-10-24 11:29 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
McClory, Paul Gerard Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-188,571 vol |
1,031,429 | |
| Filed 2023-10-24 11:26 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
McClory, Paul Gerard Joseph
4 - Director of Issuer
Holder: Cayland Trust (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-257,143 vol |
42,857 | |
| Filed 2023-10-24 11:24 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-642,857 vol |
107,143 | |
| Filed 2023-10-24 11:14 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Frazier, Vernon Jim
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-188,571 vol |
31,429 | |
| Filed 2023-10-24 11:02 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Cloud Management LLP (Indirect Ownership)
|
Options
37 - Stock split or consolidation
|
-642,857 vol |
||
| Filed 2023-10-24 11:02 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Cloud Management LLP (Indirect Ownership)
|
Options
37 - Stock split or consolidation
|
-642,857 vol |
107,143 | |
| Filed 2023-10-24 10:59 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Harry Resin (Indirect Ownership)
|
Options
37 - Stock split or consolidation
|
-1,714,286 vol |
||
| Filed 2023-10-24 10:55 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Could Management LLC (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-857,143 vol |
||
| Filed 2023-10-24 10:55 Tx date 2023-10-24 |
$PHRX
Pharmadrug Inc. |
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Could Management LLC (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-857,143 vol |
142,857 | |
| Filed 2023-09-07 09:53 Tx date 2023-09-06 |
$PHRX
Pharmadrug Inc. |
Steen, Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-07 09:53 Tx date 2023-09-06 |
$PHRX
Pharmadrug Inc. |
Steen, Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-08-04 15:29 Tx date 2021-02-27 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-250,000 vol |
1,348,022 | |
| Filed 2022-08-04 15:28 Tx date 2021-01-10 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-225,000 vol |
1,598,022 | |
| Filed 2022-08-04 15:26 Tx date 2020-08-16 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-200,000 vol |
475,000 | |
| Filed 2022-08-03 18:54 Tx date 2022-08-02 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: Daniel Cohen - RESP (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$9,794
+195,893 vol $0.05 each |
195,893 | |
| Filed 2022-08-03 18:53 Tx date 2018-08-16 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: Daniel Cohen - RESP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-08-03 18:52 Tx date 2022-08-02 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: Daniel Cohen - RRSP (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$18,190
+363,801 vol $0.05 each |
363,801 | |
| Filed 2022-08-03 18:52 Tx date 2018-08-16 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: Daniel Cohen - RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-08-03 18:50 Tx date 2022-08-02 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$16,176
+323,525 vol $0.05 each |
3,019,570 | |
| Filed 2022-05-30 11:40 Tx date 2022-05-27 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: 7725434 Canada Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,250,000 vol |
1,871,500 | |
| Filed 2022-05-30 11:39 Tx date 2022-05-27 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: 7725434 Canada Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+1,250,000 vol $0.04 each |
2,550,000 | |
| Filed 2022-05-27 14:30 Tx date 2020-07-17 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: 7725434 Canada Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+621,500 vol |
621,500 | |
| Filed 2022-05-27 14:25 Tx date 2021-09-24 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-250,000 vol |
3,750,000 | |
| Filed 2022-05-27 14:20 Tx date 2020-12-18 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+2,696,045 vol |
||
| Filed 2020-12-18 17:18 Tx date 2020-12-18 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+2,696,045 vol |
||
| Filed 2020-07-23 17:14 Tx date 2020-07-17 |
$PHRX
Pharmadrug Inc. |
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: 7725434 Canada Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,243,000 vol |
||
| Filed 2022-01-13 14:15 Tx date 2018-08-09 |
$PHRX
Pharmadrug Inc. |
McClory, Paul Gerard Joseph
4 - Director of Issuer
Holder: Cayland Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2021-08-31 12:33 Tx date 2021-08-30 |
$PHRX
Pharmadrug Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
750,000 | |
| Filed 2021-08-31 12:32 Tx date 2021-08-30 |
$PHRX
Pharmadrug Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-31 12:32 Tx date 2021-08-30 |
$PHRX
Pharmadrug Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|